Tianyi Liu

机构：Pennsylvania State University, University of Toronto, Guangxi Normal University · ORCID：0009-0007-8084-4690

发表论文 14 篇 · 总被引 435 次 · h-index 8

代表论文

• CRISPR-based detection of SARS-CoV-2: A review from sample to result (2021 · Biosensors and Bioelectronics · 被引 149)
• Sensitive and specific CRISPR-Cas12a assisted nanopore with RPA for Monkeypox detection (2023 · Biosensors and Bioelectronics · 被引 72)
• Dimethyl fumarate reduces the risk of mycotoxins via improving intestinal barrier and microbiota (2017 · Oncotarget · 被引 57)
• STAMP-Based Digital CRISPR-Cas13a for Amplification-Free Quantification of HIV-1 Plasma Viral Loads (2023 · ACS Nano · 被引 45)
• Sample‐to‐answer salivary miRNA testing: New frontiers in point‐of‐care diagnostic technologies (2024 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · 被引 31)
• In Silico Analyses for Key Genes and Molecular Genetic Mechanism in Epilepsy and Alzheimer’s Disease (2018 · CNS & Neurological Disorders - Drug Targets · 被引 30)